Connect your AI

Sera Prognostics SERA Stock-Based Comp

Stock-Based Comp at other companies

Myriad GeneticsMYGN

$6.5M-31.6%

Labcorp HoldingsLH

$31.7M-3.4%

Quest DiagnosticsDGX

$20M-9.1%

Natera, Inc.NTRA

$95.11M+22.2%

BillionToOne, Inc. BLLN

$6.51M+174%

RevvityRVTY

$8.72M+12.7%

Other financials

Income statement

Revenue$14.0K-63.2%

Operating income-$9.4M-1.2%

Net income-$8.4M-2.6%

EPS (diluted)-$0.17+15.0%

Balance sheet

Cash & equivalents$4.2M-20.2%

Total debt$2.5M+286%

Total equity$67.6M-28.7%

Total assets$93.5M-20.8%

Cash flow

Operating cash flow-$8.8M-16.2%

CapEx$8.0K+167%

Free cash flow-$8.8M-16.2%

Valuation

Market cap$71.27M+5.0%

Enterprise value$69.6M+9.6%

P/S1,250.3×+622×

Profitability

Operating margin-64,235.1%-8,092,342pp

Net margin-56,386%+1,586,573pp

FCF margin-48,377.2%-673,104pp

Returns & leverage

Return on equity-39.6%-1.6pp

Debt / equity0×0.0×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sera Prognostics's stock-based comp?: Sera Prognostics (SERA) reported stock-based comp of $835K in Q1 2026.
How has Sera Prognostics's stock-based comp changed year-over-year?: Sera Prognostics's stock-based comp decreased by 44.1% year-over-year, from $1.49M to $835K.
What is the long-term trend for Sera Prognostics's stock-based comp?: Over 4 years (2021 to 2025), Sera Prognostics's stock-based comp has grown at a 13.0% compound annual growth rate (CAGR), from $3.13M to $5.11M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.